Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Revance Therapeutics, Inc. regarding a class action lawsuit due to alleged misleading statements and material breaches related to a Distribution Agreement with Teoxane [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from February 29, 2024, to December 6, 2024 [1]. - Allegations include that Revance was in material breach of the Distribution Agreement with Teoxane, which granted exclusive rights to import, market, promote, sell, and distribute Teoxane's dermal fillers [1]. - The breach allegedly increased the risk of litigation and monetary and reputational harm to the company [1]. - The allegations suggest that the company's public statements were materially false and misleading during the class period [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by March 4, 2025, to potentially be appointed as lead plaintiff [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [2]. - Participation in the case incurs no cost or obligation for the shareholders [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

As filed with the Securities and Exchange Commission on September 16, 2024. Registration No. 333-281987 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ELEVAI LABS INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Delaware 5912 85-1399981 (I.R.S. Employer Identification No. ...

As filed with the Securities and Exchange Commission on September 6, 2024. Registration No. 333-[*] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ELEVAI LABS INC. (Exact name of registrant as specified in its charter) 120 Newport Center Drive, Ste. 250 Newport Beach, CA 92660 (866) 794-4940 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Graydon Ben ...